Providers/Grant Support
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals, Inc.
Credits Available
- Physicians — maximum of 0.5 AMA PRA Category 1 CreditsTM
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Program Overview
The online activity will be a 20-minute Seminar in Depth featuring an expert faculty intended to enable dermatology providers to increase their knowledge and competence on the latest clinical updates in bullous pemphigoid.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Describe the heterogeneity in clinical presentation of bullous pemphigoid (BP)
- Apply recent clinical data for targeted therapies to treatment selection for patients with BP
Faculty
Prince Adotama, MD
NYU Grossman School of Medicine, New York, NY
Donna Culton, MD, PhD
University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared®. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflict of Interest
Prince Adotama, MD
Advisory Board: Bristol-Myers, Regeneron, Galderma, Janssen
Donna A. Culton, MD, PhD
Advisory Board: Argenx, Regeneron, Sanofi Genzyme
Grant/Research Support: Lilly, Regeneron, Cabaletta, Incyte
Consultant: Sitala, iCell
Royalty: UpToDate
Ownership Interest (privately held): Incyte
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be immediately available to the participant.
Disclosure of Unlabeled Use
The Institute requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected]